First patients recruited in Combat-JUDO!

October 14, 2015 - News story

Beta-JUDO (Beta-cell function in Juvenile Diabetes and Obesity) is a collaborative project funded by the Seventh Framework Programme of the European Commission. The main aim of the Beta-JUDO project is to develope innovative therapeutic strategies by increasing pharmacology-based alternatives targeting insulin hypersecretion for the treatment of young obese individuals.

Combat-JUDO (Combating Juvenile Diabetes and Obesity through normalization of beta-cell function) is a part of the Beta-JUDO project.

The Combat-JUDO study is a double-blinded, randomized two arms study comparing  lifestyle intervention + active study drug or placebo in adolescents with obesity.

Scandinavian CRO is a partner in this project and responsible for coordinating the clinical study.  The study is conducted in Uppsala University Hospital and Salzburg State Hospital.

We are happy to announce that the first patiens were recruited in September.

« Back